Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations - 04/05/22
Doi : 10.1016/j.amjmed.2021.12.019
Maja Berges, BS a, Keith Foster, MD, MBA, FAAPMR a, Jennifer Foster, MD, MBA, FACP a, Lisa Martinez, MD a, Sean Martinez, MD a, Benjamin Fiedler, BS a, David L. DeMets, PhD b, Dennis G. Maki, MD b, Charles H. Hennekens, MD, DrPH a, ⁎ 
a Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton
b University of Wisconsin School of Medicine and Public Health, Madison
⁎Requests for reprints should be addressed to Charles H. Hennekens, First Sir Richard Doll Professor and Senior Academic Advisor to the Dean, Charles E. Schmidt College of Medicine, Florida Atlantic University, 2800 S. Ocean Blvd. PHA, Boca Raton, FL 33432.First Sir Richard Doll Professor and Senior Academic Advisor to the DeanCharles E. Schmidt College of MedicineFlorida Atlantic University2800 S. Ocean Blvd. PHABoca RatonFL33432
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
El texto completo de este artículo está disponible en PDF.
Esquema
| Funding: None. |
|
| Conflict of Interest: DLD reports that he is partially supported by a National Institutes of Health grant to the University of Wisconsin for the Clinical Translational Science Award for statistical consultation and collaboration and administrative leadership, serves or has recently served as an independent biostatistician in an advisory role to investigators and sponsors often as a member of independent DSMBs for Actelion, Amgen, Astellas, AstraZeneca, Biotronik, Boehringer Ingelheim, CVRx, Genentech, GlaxoSmithKline, Novartis, Merck, Pfizer, Roche, Sanofi Aventis, Takeda, Millennium, the Duke Clinical Research Institute, the Population Health Research Institute of McMaster University, and Harvard Partners; receives royalties from publishers of the 3 textbooks that he has coauthored and edited; has tax sheltered retirement accounts in mutual funds with Fidelity and Morgan Stanley; and has a small amount of stock with Intel. |
|
| CHH reports that he serves as an independent scientist in an advisory role to investigators and sponsors as chair of data monitoring committees for Amgen, British Heart Foundation, Cadila, Canadian Institutes of Health Research, DalCor, and Regeneron, and to the US Food and Drug Administration, and UpToDate; receives royalties for authorship or editorship of 3 textbooks and as co-inventor on patents for inflammatory markers and cardiovascular disease that are held by Brigham and Women's Hospital; has an investment management relationship with the West-Bacon Group within SunTrust Investment Services, which has discretionary investment authority; does not own any common or preferred stock in any pharmaceutical or medical device company. |
|
| All other authors report no disclosures. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2022
Elsevier Inc. Reservados todos los derechos.
Vol 135 - N° 5
P. 547-549 - mai 2022 Regresar al número
Artículo precedente
- A Letter to Internal Medicine Residents Serving on the Front Lines of the Pandemic: We See, Hear, and Feel You
- Lindsay Sonstein, Matthew Dacso
- Choose Wisely: Clinical Diagnostic Reasoning Over Technological Expediency
- L. Maria Belalcazar, Roshaneh Ali
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.